Lorazepam (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lorazepam" in Slovenian language version.

refsWebsite
Global rank Slovenian rank
4th place
8th place
2nd place
5th place
low place
3,919th place
222nd place
163rd place
low place
8,895th place
149th place
140th place
1st place
2nd place
7,927th place
2,767th place

benzo.org.uk

ccmjournal.com

doi.org

  • Greenblatt DJ; Shader RI; Franke K; Maclaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E (1991). »Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans«. J Pharm Sci. 68 (1): 57–63. doi:10.1002/jps.2600680119. PMID 31453.[mrtva povezava]
  • Greenblatt DJ; von Moltke LL; Ehrenberg BL; Harmatz JS; Corbett KE; Wallace DW; Shader RI (2000). »Kinetics and dynamics of lorazepam during and after continuous intravenous infusion«. Crit Care Med. 28 (8): 2750–2757. doi:10.1097/00003246-200008000-00011. PMID 10966246.
  • Papini O; da Cunha SP; da Silva Mathes Ado C; Bertucci C; Moisés EC; de Barros Duarte L; de Carvalho Cavalli R; Lanchote VL (2006). »Kinetic disposition of lorazepam with a focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples« (PDF). J Pharm Biomed Anal. 40 (2): 397–403. doi:10.1016/j.jpba.2005.07.021. PMID 16143486.
  • Pompéia S; Manzano GM; Tufik S; Bueno OFA (2005). »What makes lorazepam different from other benzodiazepines?"«. J Physiol. 569 (2): 709. doi:10.1113/jphysiol.2005.569005. PMID 16322061.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Greenblatt DJ; Shader RI; Franke K; Maclaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E (1991). »Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans«. J Pharm Sci. 68 (1): 57–63. doi:10.1002/jps.2600680119. PMID 31453.[mrtva povezava]
  • Greenblatt DJ; von Moltke LL; Ehrenberg BL; Harmatz JS; Corbett KE; Wallace DW; Shader RI (2000). »Kinetics and dynamics of lorazepam during and after continuous intravenous infusion«. Crit Care Med. 28 (8): 2750–2757. doi:10.1097/00003246-200008000-00011. PMID 10966246.
  • Papini O; da Cunha SP; da Silva Mathes Ado C; Bertucci C; Moisés EC; de Barros Duarte L; de Carvalho Cavalli R; Lanchote VL (2006). »Kinetic disposition of lorazepam with a focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples« (PDF). J Pharm Biomed Anal. 40 (2): 397–403. doi:10.1016/j.jpba.2005.07.021. PMID 16143486.
  • Kemper N; Poser W; Poser S. (5. december 1980). »[Benzodiazepine dependence: addiction potential of the benzodiazepines is greater than previously assumed (author's transl)]«. Deutsche medizinische Wochenschrift (1946). 105 (49): 1707–12. PMID 7439058.
  • Pompéia S; Manzano GM; Tufik S; Bueno OFA (2005). »What makes lorazepam different from other benzodiazepines?"«. J Physiol. 569 (2): 709. doi:10.1113/jphysiol.2005.569005. PMID 16322061.

rxlist.com

sciencedirect.com

web.archive.org

wiley.com

www3.interscience.wiley.com

  • Greenblatt DJ; Shader RI; Franke K; Maclaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E (1991). »Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans«. J Pharm Sci. 68 (1): 57–63. doi:10.1002/jps.2600680119. PMID 31453.[mrtva povezava]